BlackRock Health Sciences Trust (NYSE:BME) Stock Price Passes Below Fifty Day Moving Average – Here’s What Happened

BlackRock Health Sciences Trust (NYSE:BME) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $41.28 and traded as low as $37.51. BlackRock Health Sciences Trust shares last traded at $37.6960, with a volume of 138,243 shares changing hands.

BlackRock Health Sciences Trust Stock Performance

The business’s 50-day simple moving average is $41.28 and its two-hundred day simple moving average is $40.01.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be given a dividend of $0.2621 per share. This represents a c) annualized dividend and a dividend yield of 8.3%. The ex-dividend date is Monday, June 15th.

Institutional Trading of BlackRock Health Sciences Trust

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. increased its stake in BlackRock Health Sciences Trust by 285,436.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock worth $166,414,000 after buying an additional 4,044,638 shares during the period. 1607 Capital Partners LLC boosted its stake in shares of BlackRock Health Sciences Trust by 49.5% in the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after buying an additional 75,958 shares during the period. Invesco Ltd. grew its holdings in BlackRock Health Sciences Trust by 7.6% during the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after acquiring an additional 15,381 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of BlackRock Health Sciences Trust by 18.8% in the 3rd quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after purchasing an additional 34,218 shares in the last quarter. Finally, Royal Bank of Canada lifted its position in shares of BlackRock Health Sciences Trust by 13.0% during the 4th quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock worth $6,600,000 after purchasing an additional 18,442 shares during the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.